propranolol has been researched along with Atrioventricular Nodal Reentrant Tachycardia in 13 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Antiarrhythmic therapy was chosen for 3-7 days by modified chronic electrophysiological study at three stages: (1) the efficacy of a drug, its action onset and termination were defined; (2) a dosage was chosen on an individual basis and the duration of drug potency was specified; (3) the dosage regimen of a drug given as a course therapy was confirmed by the results of trials." | 2.67 | [Evaluation of the possibility of selection of individual anti-arrhythmia therapy]. ( Antonchenko, IV; Borisova, EV; Chekhov, AM; Gimrikh, EO; Plekhanov, IG; Popov, SV; Savenkova, GM, 1991) |
| "Propranolol was the most frequently used first-line AM (92% and 95%)." | 1.91 | Multicenter cohort study on duration of antiarrhythmic medication for supraventricular tachycardia in infants. ( Arola, A; Happonen, JM; Hiippala, A; Leino, T; Leskinen, M; Linnanmäki, A; Mecklin, M; Poutanen, T; Ruotsalainen, H, 2023) |
| "Verapamil was used in one infant with AV node reentry tachycardia." | 1.29 | Efficacy and risks of medical therapy for supraventricular tachycardia in neonates and infants. ( Saul, JP; Walsh, EP; Weindling, SN, 1996) |
| "AV nodal reentrant tachycardia was inducible by ventricular premature stimulation but was always nonsustained, terminating with block in the anterograde slow pathway." | 1.28 | Atrioventricular nodal reentrant tachycardia initiated by catecholamine-induced ventricular tachycardia. A case report. ( Mann, DE; Marmont, P; Reiter, MJ; Shultz, J, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 7 (53.85) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Mecklin, M | 1 |
| Linnanmäki, A | 1 |
| Hiippala, A | 1 |
| Leino, T | 1 |
| Arola, A | 1 |
| Leskinen, M | 1 |
| Ruotsalainen, H | 1 |
| Happonen, JM | 1 |
| Poutanen, T | 1 |
| Ciriello, GD | 1 |
| Colonna, D | 1 |
| Papaccioli, G | 1 |
| Correra, A | 1 |
| Romeo, E | 1 |
| Palladino, MT | 1 |
| Cioppa, ND | 1 |
| Russo, MG | 1 |
| Sarubbi, B | 1 |
| Brubaker, S | 1 |
| Long, B | 1 |
| Koyfman, A | 1 |
| Natale, A | 1 |
| Klein, G | 1 |
| Yee, R | 1 |
| Thakur, R | 1 |
| Weindling, SN | 1 |
| Saul, JP | 1 |
| Walsh, EP | 1 |
| Lin, LJ | 1 |
| Lin, JL | 1 |
| Lai, LP | 1 |
| Chen, JH | 1 |
| Tseng, YZ | 1 |
| Lien, WP | 1 |
| Chen, MC | 1 |
| Guo, GB | 1 |
| Nanthakumar, K | 1 |
| Dorian, P | 1 |
| Paquette, M | 1 |
| Hutchison, S | 1 |
| Andrews, J | 1 |
| Newman, D | 1 |
| Antonchenko, IV | 1 |
| Gimrikh, EO | 1 |
| Popov, SV | 1 |
| Chekhov, AM | 1 |
| Borisova, EV | 1 |
| Savenkova, GM | 1 |
| Plekhanov, IG | 1 |
| Littmann, L | 1 |
| Svenson, RH | 1 |
| Tomcsanyi, I | 1 |
| Hehrlein, C | 1 |
| Gallagher, JJ | 1 |
| Bharati, S | 1 |
| Lev, M | 1 |
| Splinter, R | 1 |
| Tatsis, GP | 1 |
| Tuntelder, JR | 1 |
| Mann, DE | 1 |
| Marmont, P | 1 |
| Shultz, J | 1 |
| Reiter, MJ | 1 |
| Shenasa, M | 1 |
| Lacombe, P | 1 |
| Côté, MA | 1 |
| Sadr-Ameli, MA | 1 |
| Nadeau, R | 1 |
| Prochaczek, F | 1 |
| Becker, A | 1 |
| Matuszewska, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Simulation of Adenosine Push Methods for Treatment of SVT Using Agitated Saline Visualized by Ultrasound[NCT04051541] | 20 participants (Actual) | Interventional | 2019-05-06 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for propranolol and Atrioventricular Nodal Reentrant Tachycardia
| Article | Year |
|---|---|
Alternative Treatment Options for Atrioventricular-Nodal-Reentry Tachycardia: An Emergency Medicine Review.
Topics: Adenosine; Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Calcium Channel Blockers; Diltiazem; | 2018 |
1 trial available for propranolol and Atrioventricular Nodal Reentrant Tachycardia
| Article | Year |
|---|---|
[Evaluation of the possibility of selection of individual anti-arrhythmia therapy].
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Disopyramide; Humans; Middle Aged; P | 1991 |
11 other studies available for propranolol and Atrioventricular Nodal Reentrant Tachycardia
| Article | Year |
|---|---|
Multicenter cohort study on duration of antiarrhythmic medication for supraventricular tachycardia in infants.
Topics: Anti-Arrhythmia Agents; Cohort Studies; Humans; Infant; Propranolol; Tachycardia, Atrioventricular N | 2023 |
Triple Antiarrhythmic Therapy in Newborns with Refractory Atrioventricular Reentrant Tachycardia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Flecainide; Humans; Infant; Infant, Newborn; Propranolol; Tachyc | 2023 |
Shortening of fast pathway refractoriness after slow pathway ablation. Effects of autonomic blockade.
Topics: Adult; Atrioventricular Node; Atropine; Cardiac Pacing, Artificial; Catheter Ablation; Female; Human | 1994 |
Efficacy and risks of medical therapy for supraventricular tachycardia in neonates and infants.
Topics: Anti-Arrhythmia Agents; Catheter Ablation; Digoxin; Electrocardiography; Esophagus; Female; Follow-U | 1996 |
Effects of pharmacological autonomic blockade on dual atrioventricular nodal pathways physiology in patients with slow-fast atrioventricular nodal reentrant tachycardia.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Atrioventricular Node; Atropine; Auton | 1998 |
Junctional tachycardia during radiofrequency ablation of the slow pathway in patients with AV nodal reentrant tachycardia: effects of autonomic blockade.
Topics: Atrioventricular Node; Atropine; Autonomic Nerve Block; Autonomic Nervous System; Catheter Ablation; | 1999 |
Effect of physiological mechanical perturbations on intact human myocardial repolarization.
Topics: Action Potentials; Aged; Atropine; Autonomic Agents; Cardiac Pacing, Artificial; Female; Heart; Hear | 2000 |
Modification of atrioventricular node transmission properties by intraoperative neodymium-YAG laser photocoagulation in dogs.
Topics: Animals; Atrioventricular Node; Dogs; Feasibility Studies; Female; Fibrosis; Follow-Up Studies; Hear | 1991 |
Atrioventricular nodal reentrant tachycardia initiated by catecholamine-induced ventricular tachycardia. A case report.
Topics: Catecholamines; Exercise; Heart Ventricles; Humans; Isoproterenol; Male; Middle Aged; Propranolol; T | 1991 |
Depressant effect on the retrograde atrioventricular nodal conduction of beta-adrenergic blockade by propranolol in humans.
Topics: Adult; Aged; Atrioventricular Node; Bundle of His; Depression, Chemical; Electric Stimulation; Elect | 1987 |
[Occurrence of latent retrograde atrioventricular conduction reaching the atrial conduction pathways in a patient with paroxysmal tachycardia of the re-entry type within the atrioventricular node after administration of propranolol].
Topics: Atrioventricular Node; Electrocardiography; Female; Heart Conduction System; Humans; Middle Aged; Pr | 1987 |